查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596646

空间基因组学和转录组学市场：按产品、技术和最终用户划分 - 2025-2030 年全球预测

Spatial Genomics & Transcriptomics Market by Product (Consumables, Instruments, Software), Technology (Immunohistochemistry Screening, Spatial Genomics, Spatial Transcriptomics), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年空间基因组学和转录组学市场价值为78233万美元，预计2024年将达到87903万美元，复合年增长率为13.62%，到2030年将达到191312万美元，预计将达到1000万美元。

空间基因组学和转录组学是关注组织内基因的空间组织和表达的前沿领域。这些领域的需求源自于传统基因组技术的局限性，这些技术往往忽略基因表现的空间背景，从而错过对细胞功能、疾病进展和组织结构的重要见解。其应用范围从癌症研究和神经科学到发育生物学和个人化医学，其中了解基因活动的空间排列可以为标靶治疗和介入提供资讯。典型的最终用户包括专注于药物发现和开发的学术研究机构、生技公司和製药公司。

主要市场统计
基准年[2023] 78233万美元
预测年份 [2024] 8.7903亿美元
预测年份 [2030] 1,913,120,000 美元
复合年增长率（%） 13.62%

市场洞察强调，在技术进步和定序成本下降的推动下，对高解析度空间成像和全面分子分析的需求不断增长正在推动成长。此外，人工智慧和机器学习在资料分析中的集合成为从复杂的空间资料中提取有意义的见解提供了新的维度。然而，挑战包括资料复杂性、高解析度成像技术的高成本以及对高技能专家的需求等技术限制。有关基因组学资料隐私的监管障碍和道德考虑也是限制因素。

有潜在机会开发更具成本效益和易于使用的技术，改进资料整合方法，并增强易于使用的分析软体。工业界和学术界之间加强合作将刺激创新，研发投资将带来多重功能和单细胞分析技术的突破。由于商业性利益的增加和旨在扩大产品系列的策略联盟，市场正在迅速发展。最佳创新领域包括用于资料可视化的生物资讯软体、整合多组体学资料的平台以及新颖的单细胞空间分析。这个充满活力的市场必须不断适应技术进步和不断变化的监管环境，而彻底的市场分析对于持续成长和竞争力至关重要。

市场动态：揭示快速发展的空间基因组学和转录组学市场的关键市场洞察

供需的动态交互作用正在改变空间基因组学和转录组学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病流行以及准确有效的药物设计的必要性
    • 提高基因组学和定序技术的监管和道德接受度
    • 更多地使用空间分析来推进精准医学和诊断
  • 市场限制因素
    • 新兴经济体医疗保健专业人员对基因组医学的认知较低
  • 市场机会
    • 太空生物学的技术进步主要集中在人工智慧、3D 列印和标准化诊断生物标记上
    • 增加基因组学和转录组学研究的公共和私人资助
  • 市场挑战
    • 基因和单细胞定序的报销差异和不确定性

波特五力：驾驭空间基因体学与转录组学市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解空间基因组学和转录组学市场的外部影响

外部宏观环境因素在塑造空间基因组学和转录组学市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解空间基因体学和转录组学市场的竞争格局

空间基因组学和转录组学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵空间基因组学和转录组学市场供应商的绩效评估

FPNV 定位矩阵是评估空间基因组学和转录组学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製空间基因组学和转录组学市场的成功之路

空间基因组学和转录组学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的流行和开发精准有效药物的必要性
      • 改善基因组学和定序技术的监管和道德接受度
      • 空间分析的新用途推进精准医学和诊断
    • 抑制因素
      • 新兴经济体的医疗保健专业人员对基因组医学的认识有限
    • 机会
      • 太空生物学的技术进步主要集中在人工智慧、3D列印和标准化诊断生物标记。
      • 增加基因组学和转录组学研究的公共和私人资助
    • 任务
      • 基因和单细胞定序的报销差异和不确定性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章空间基因组学和转录组学市场：副产品

  • 消耗品
  • 装置
  • 软体

第七章 空间基因体学与转录组学市场：依技术分类

  • 免疫组织化学筛检
  • 空间基因体学
    • 生化技术
    • 萤光原位杂合反应
    • 基因组扰动工具
    • 大规模平行定定序
    • 使用显微镜进行生物 DNA 成像
  • 空间转录组学
    • 原位定序
    • 切片顺序
    • 基于序列的方法
    • 体内转录组分析

第八章空间基因组学和转录组学市场：按最终用途

  • 学术机构
  • 诊断机构
  • 药品製造商
  • 转化研究

第九章美洲空间基因组学和转录组学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区空间基因体学与转录组学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的空间基因组学和转录组学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • OmicsVeu 推出广泛的空间生物学产品线
    • Bio-Rad 在 AGBT 2022 上推出 SEQuoia Express 链 RNA 文库製备试剂套件
    • Lexogen 推出 CORALL RNA-Seq V2，这是一种快速、灵活的全转录组 RNA-Seq 文库製备试剂套件。
    • NanoString发布新的nCounter Pro分析系统
    • Singular Genomics 与 QIAGEN 合作，为 G4定序平台提供 QIAseq 试剂套件
    • Fulgent Genetics 宣布对空间基因组学进行策略性投资
    • Singular Genomics 与 Lexogen 合作，为 G4定序平台实现 RNA 文库製备
    • Bio-Techne 和 Akoya Biosciences 合作，以业界领先的速度和分辨率实现自动化空间多组体学工作流程
    • Andor 和 Akoya Biosciences 合作进军太空体学市场
  • 战略分析和建议

公司名单

  • 10X Genomics, Inc.
  • Akoya Biosciences, Inc.
  • Arima Genomics, Inc.
  • AtlasXomics Inc.
  • Axcelead Drug Discovery Partners Inc.
  • BGI Australia
  • Bio-Techne Corporation
  • BioSpyder Technologies Inc.
  • Bruker Corporation
  • Bucher Biotec AG
  • CD Genomics
  • CeGaT GmbH
  • Dovetail Genomics, LLC
  • Easi-Genomics
  • Enzo Life Sciences, Inc.
  • Eurofins Genomics
  • Fulgent Genetics
  • Genomic Vision SA
  • Illumina, Inc.
  • Indivumed Group
  • Ionpath, Inc.
  • Lunaphore Technologies SA
  • Miltenyi Biotec
  • Nanostring Technologies, Inc.
  • Natera Inc.
  • Novogene Co, Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • PT Pandu Biosains
  • Rarecyte, Inc
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Single Cell Discoveries
  • Single Technologies AB
  • Singular Genomics System, Inc.
  • Spatial Genomics
  • Springer Nature
  • Standard BioTools Inc.
  • Tecan Group Ltd.
  • Ultivue, Inc.
  • Veracyte, Inc.
  • Veranome Biosystems, LLC
  • Vizgen Corporation
Product Code: MRR-F611BFBC5D35

The Spatial Genomics & Transcriptomics Market was valued at USD 782.33 million in 2023, expected to reach USD 879.03 million in 2024, and is projected to grow at a CAGR of 13.62%, to USD 1,913.12 million by 2030.

Spatial genomics and transcriptomics represent cutting-edge fields that focus on the spatial organization and expression of genes within tissues. The necessity of these fields stems from the limitations of conventional genomic technologies, which often disregard the spatial context of gene expression, thus missing critical insights into cellular function, disease progression, and tissue architecture. Applications are vast, ranging from cancer research and neuroscience to developmental biology and personalized medicine, where understanding the spatial arrangement of gene activity can inform targeted therapies and interventions. Key end-users include academic research institutions, biotechnology companies, and pharmaceutical industries focusing on drug discovery and development.

KEY MARKET STATISTICS
Base Year [2023] USD 782.33 million
Estimated Year [2024] USD 879.03 million
Forecast Year [2030] USD 1,913.12 million
CAGR (%) 13.62%

Market insights highlight that the increasing demand for high-resolution spatial imaging and comprehensive molecular profiling is driving growth, fueled by technological advancements and decreasing sequencing costs. Additionally, the integration of artificial intelligence and machine learning in data analysis provides new dimensions for extracting meaningful insights from complex spatial data. However, challenges include technical constraints such as data complexity, high costs of high-resolution imaging technologies, and the need for highly skilled professionals. Regulatory hurdles and ethical considerations regarding data privacy in genomics also pose limitations.

Potential opportunities lie in developing more cost-effective and accessible technologies, improving data integration methods, and enhancing user-friendly analytical software. Increased collaboration between industry and academic sectors can spur innovation, while investment in R&D can lead to breakthroughs in multiplexing capabilities and single-cell analysis techniques. The market is rapidly evolving, underscored by increasing commercial interest and strategic partnerships aimed at expanding product portfolios. Best areas for innovation include bioinformatics software for data visualization, platforms for integrating multi-omics data, and novel single-cell spatial assays. This dynamic market requires continual adaptation to technological advancements and shifting regulatory landscapes, making thorough market analysis crucial for sustained growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for designing accurate and effective drugs
    • Improving regulatory and ethical acceptance of genomics and sequencing technologies
    • Emerging use of spatial analysis to advance precision medicine & diagnostics
  • Market Restraints
    • Limited awareness among healthcare professionals about genomic medicine in developing economies
  • Market Opportunities
    • Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
    • Rising public and private funding for genomics & transcriptomics research
  • Market Challenges
    • Reimbursement inconsistency and uncertainty in gene & single-cell sequencing

Porter's Five Forces: A Strategic Tool for Navigating the Spatial Genomics & Transcriptomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spatial Genomics & Transcriptomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spatial Genomics & Transcriptomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spatial Genomics & Transcriptomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spatial Genomics & Transcriptomics Market

A detailed market share analysis in the Spatial Genomics & Transcriptomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spatial Genomics & Transcriptomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spatial Genomics & Transcriptomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spatial Genomics & Transcriptomics Market

A strategic analysis of the Spatial Genomics & Transcriptomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Software.
  • Based on Technology, market is studied across Immunohistochemistry Screening, Spatial Genomics, and Spatial Transcriptomics. The Spatial Genomics is further studied across Biochemical Techniques, Fluorescence in Situ Hybridization, Genome Perturbation Tools, Massively-Parallel Sequencing, and Microscopy-Based Live DNA Imaging. The Spatial Transcriptomics is further studied across In Situ Sequencing, Microtomy Sequencing, Sequencing-Based Methods, and Transcriptome In-vivo Analysis.
  • Based on End-Use, market is studied across Academic Institutes, Diagnostic Institutes, Pharmaceutical Manufacturer, and Translational Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for designing accurate and effective drugs
      • 5.1.1.2. Improving regulatory and ethical acceptance of genomics and sequencing technologies
      • 5.1.1.3. Emerging use of spatial analysis to advance precision medicine & diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness among healthcare professionals about genomic medicine in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
      • 5.1.3.2. Rising public and private funding for genomics & transcriptomics research
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software

7. Spatial Genomics & Transcriptomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Immunohistochemistry Screening
  • 7.3. Spatial Genomics
    • 7.3.1. Biochemical Techniques
    • 7.3.2. Fluorescence in Situ Hybridization
    • 7.3.3. Genome Perturbation Tools
    • 7.3.4. Massively-Parallel Sequencing
    • 7.3.5. Microscopy-Based Live DNA Imaging
  • 7.4. Spatial Transcriptomics
    • 7.4.1. In Situ Sequencing
    • 7.4.2. Microtomy Sequencing
    • 7.4.3. Sequencing-Based Methods
    • 7.4.4. Transcriptome In-vivo Analysis

8. Spatial Genomics & Transcriptomics Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academic Institutes
  • 8.3. Diagnostic Institutes
  • 8.4. Pharmaceutical Manufacturer
  • 8.5. Translational Research

9. Americas Spatial Genomics & Transcriptomics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Spatial Genomics & Transcriptomics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. OmicsVeu Launches An Extensive Line Of Spatial Biology
    • 12.3.2. Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
    • 12.3.3. Lexogen Introduces CORALL RNA-Seq V2 - a fast and flexible whole transcriptome RNA-Seq Library Prep Kit.
    • 12.3.4. NanoString Launches New nCounter Pro Analysis System
    • 12.3.5. Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
    • 12.3.6. Fulgent Genetics Announces Strategic Investment in Spatial Genomics
    • 12.3.7. Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
    • 12.3.8. Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
    • 12.3.9. Andor and Akoya Biosciences to Collaborate in Spatial Omics market
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10X Genomics, Inc.
  • 2. Akoya Biosciences, Inc.
  • 3. Arima Genomics, Inc.
  • 4. AtlasXomics Inc.
  • 5. Axcelead Drug Discovery Partners Inc.
  • 6. BGI Australia
  • 7. Bio-Techne Corporation
  • 8. BioSpyder Technologies Inc.
  • 9. Bruker Corporation
  • 10. Bucher Biotec AG
  • 11. CD Genomics
  • 12. CeGaT GmbH
  • 13. Dovetail Genomics, LLC
  • 14. Easi-Genomics
  • 15. Enzo Life Sciences, Inc.
  • 16. Eurofins Genomics
  • 17. Fulgent Genetics
  • 18. Genomic Vision SA
  • 19. Illumina, Inc.
  • 20. Indivumed Group
  • 21. Ionpath, Inc.
  • 22. Lunaphore Technologies S.A.
  • 23. Miltenyi Biotec
  • 24. Nanostring Technologies, Inc.
  • 25. Natera Inc.
  • 26. Novogene Co, Ltd.
  • 27. Oxford Nanopore Technologies PLC
  • 28. PerkinElmer, Inc.
  • 29. PT Pandu Biosains
  • 30. Rarecyte, Inc
  • 31. Rebus Biosystems, Inc.
  • 32. Resolve Biosciences GmbH
  • 33. S2 Genomics, Inc.
  • 34. Seven Bridges Genomics
  • 35. Single Cell Discoveries
  • 36. Single Technologies AB
  • 37. Singular Genomics System, Inc.
  • 38. Spatial Genomics
  • 39. Springer Nature
  • 40. Standard BioTools Inc.
  • 41. Tecan Group Ltd.
  • 42. Ultivue, Inc.
  • 43. Veracyte, Inc.
  • 44. Veranome Biosystems, LLC
  • 45. Vizgen Corporation

LIST OF FIGURES

  • FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOCHEMICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOME PERTURBATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MASSIVELY-PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPY-BASED LIVE DNA IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROTOMY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING-BASED METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSCRIPTOME IN-VIVO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DIAGNOSTIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 240. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023